Previous studies have implicated LRRK2 polymorphisms in autoinflammatory diseases including inflammatory bowel disease (IBD), Crohn’s disease, and tuberculosis, indicating a significant connection to immune functions [27]. Here, LRRK2 is linked to Crohn disease.